Key Points
- CEO Margaret Tooth sold 1,000 Trupanion shares at an average price of $25, generating $25,000 in proceeds. The sale was made under a pre-arranged Rule 10b5-1 trading plan, reducing her holdings by 0.53% to 185,952 shares.
- Trupanion reported quarterly EPS of $0.16, exceeding the $0.11 consensus estimate, while revenue rose 11.1% year over year to $392.93 million.
- Analyst sentiment remains cautious: five analysts rate the stock “Hold” and one rates it “Buy,” producing an average rating of “Hold” and a consensus price target of $39.20.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 1,000 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $25.00, for a total transaction of $25,000.00. Following the completion of the sale, the chief executive officer directly owned 185,952 shares of the company's stock, valued at approximately $4,648,800. This trade represents a 0.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total transaction of $15,633.44.
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90.
Trupanion Trading Up 0.7%
TRUP opened at $26.32 on Wednesday. The stock has a market capitalization of $1.15 billion, a PE ratio of 49.66, a P/E/G ratio of 1.77 and a beta of 1.45. Trupanion, Inc. has a one year low of $21.16 and a one year high of $46.98. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The business's 50 day moving average price is $27.38 and its 200 day moving average price is $25.77.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company had revenue of $392.93 million during the quarter, compared to analysts' expectations of $389.72 million. During the same quarter last year, the firm earned $0.22 earnings per share. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. As a group, equities research analysts expect that Trupanion, Inc. will post 0.63 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in TRUP. Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the second quarter valued at $42,000. Parallel Advisors LLC raised its holdings in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock valued at $47,000 after buying an additional 1,722 shares during the period. Quantbot Technologies LP acquired a new position in Trupanion during the 2nd quarter worth about $89,000. Fifth Third Bancorp lifted its stake in Trupanion by 2,911.1% during the 1st quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider's stock worth $194,000 after acquiring an additional 7,336 shares in the last quarter. Finally, Arizona State Retirement System lifted its stake in Trupanion by 7.7% during the 2nd quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider's stock worth $237,000 after acquiring an additional 688 shares in the last quarter.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on TRUP shares. Stifel Nicolaus raised their price objective on Trupanion from $28.00 to $29.00 and gave the stock a "hold" rating in a research report on Thursday, August 20th. Piper Sandler cut shares of Trupanion from an "overweight" rating to a "neutral" rating and decreased their target price for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 24th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a research report on Wednesday, July 15th. Finally, Weiss Ratings downgraded shares of Trupanion from a "hold (c)" rating to a "hold (c-)" rating in a research note on Thursday, September 10th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, Trupanion currently has an average rating of "Hold" and a consensus price target of $39.20.
Read Our Latest Report on Trupanion
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet insurance company that provides medical coverage for cats and dogs. Its subscription-based policies are designed to help pet owners manage the cost of eligible veterinary care, including coverage for unexpected illnesses and injuries. Depending on the policy and jurisdiction, coverage may include diagnostic tests, surgeries, hospital stays and prescription medications, subject to applicable terms, exclusions and deductibles.
The company also develops technology intended to simplify the relationship between pet owners, veterinarians and insurers.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
